Washington University School of Medicine: Lung Neoplasms trials

The registry lists 29 Lung Neoplasms studies with Washington University School of Medicine as lead sponsor. 5 are open to participants now and 7 have results posted.

Early Phase 1 1Phase 1 6Phase 2 8No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• CARE Tool Study Aim 3RecruitingNCT07296887Not applicable
• Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian HospitalRecruitingNCT07146568Not applicable
• Ovarian-Sparing Adaptive Radiotherapy in Young Adult WomenRecruitingNCT06904365
• Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer ScreeningRecruitingNCT06898333
• Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid TumorsRecruitingNCT04354064
• One Fraction Simulation-Free Treatment With CT-Guided Stereotactic Adaptive Radiotherapy for Patients With Oligometastatic and Primary Lung TumorsCompletedNCT06236516Not applicableResults posted
• EBUS-Miniforceps Biopsy Specimen Acquisition for PD-L1 Testing in Nonsmall Cell Lung CancerCompletedNCT04159025Not applicableResults posted
• PROactive Evaluation of Function to Avoid CardioToxicityTerminatedNCT03862131Phase 2Results posted
• Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLCCompletedNCT03689855Phase 2Results posted
• MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived TumorsTerminatedNCT02669914Phase 2Results posted
• Pazopanib in Molecularly Selected Patients With Advanced NSCLCTerminatedNCT02193152Phase 2Results posted
• A Phase I/II Trial of Stereotactic Body Radiation TherapyCompletedNCT00591838Phase 1/2Results posted
• Enhanced Assistance During Radiotherapy for Unmet Essential NeedsCompletedNCT06582849Not applicable
• Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung CancerCompletedNCT05785845Not applicable
• Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial)TerminatedNCT05049863Phase 1
• Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint Blocker in NSCLCWithdrawnNCT05007769Phase 2
• Lung Cancer Screening ProtocolCompletedNCT03958253Not applicable
• Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung CancerWithdrawnNCT03166254Phase 1
• Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC)WithdrawnNCT02705339Phase 2
• SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung CancerCompletedNCT02562027Not applicable
• Genomic Landscape of CeritinibTerminatedNCT02554591
• Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid TumorsWithdrawnNCT02537561Phase 1
• Afatinib Genomic LandscapeTerminatedNCT02491775
• Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease ProgressionTerminatedNCT02431169
• Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)WithdrawnNCT02419170Early Phase 1
• Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI)TerminatedNCT02342353Phase 1
• Mechanisms of Immunosurveillance for Lung CancerCompletedNCT01710319
• Temsirolimus and Radiation for Non-Small Cell Lung CancerCompletedNCT00796796Phase 1
• Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00004176Phase 2